A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

NCT00778128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: CP-4126
DRUG: Gemcitabine

Sponsor

Clavis Pharma